Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States

James A. Karlowsky(University of Manitoba), Daniel F. Sahm(Micro Focus (United States)), Clyde Thornsberry, Mark E. Jones(Basilea Pharmaceutica (Switzerland)), Laurie J. Kelly
Antimicrobial Agents and Chemotherapy
July 28, 2002
10.1128/aac.46.8.2540-2545.2002
Cited by 369

Related Papers

Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
|Emerging infectious diseases|1998|732
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
|Annals of Clinical Microbiology and Antimicrobials|2006|384
Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide Analysis
|Clinical Infectious Diseases|2001|361
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001
|Antimicrobial Agents and Chemotherapy|2003|352